Bio + Health

The Great Health Plan Replacement

Julie Yoo Posted September 10, 2026

Your company chooses your health insurance, and you have to live with it. For the first time in decades, one of healthcare’s stickiest markets is opening up as premiums keep rising, consumers expect more, and AI makes a different kind of health plan possible.

Employer-sponsored (AKA “commercial”) healthcare is peculiar – the buyer and user are different people. The company you work for chooses one or two health insurance options and subsidizes most or all of the premiums. Healthcare is typically the company’s second largest expense after payroll, while you cover co-pays, deductibles, co-insurance, and other out-of-pocket costs. And because you change insurance plans when you change jobs every few years, the incentives aren’t long-term aligned. The plan paying for your care today may not benefit much from keeping you healthy years from now. It’s one reason employer-sponsored insurance has been called healthcare’s original sin.

But it’s a massive market, with $1T worth of spend across 150M+ Americans and highly sticky products. Employers have kept renewing contracts with legacy insurance providers, even as premiums rise by 10% or more every year. Much of that price inflation has come from the rising costs of healthcare itself, including specialty drugs and administrative bloat, and a market with historically high barriers to entry. At the same time, the consumer experience continues to be expensive, opaque, and full of surprise bills.

That has been the status quo for decades. But now, three things are happening at the same time:

  • First, employer healthcare economics have risen to the point that the majority of employers are shopping for alternatives, either to switch to lower cost health plans or drop traditional health insurance entirely.
  • Second, consumers have an increasingly high standard for care when it comes to access, cost, experience, personalization, and quality. This is partly the result of abundant DTC and now AI-native healthcare services that have normalized consumers seeking care directly and paying out of pocket, then asking insurers and employers if they’ll cover or reimburse it.
  • Third, AI is lowering the fixed-cost barrier to building and operating a health plan. Supporting plan members, helping with care navigation, underwriting risk, reviewing claims, remitting payments – all of these functions historically required large teams to execute, but AI is now the leverage to do all of these more efficiently.

These shifts are spurring a generational replacement cycle in commercial health insurance, in which employers are increasingly looking to move to Alternative Health Plans, or AHPs.

A new wave of challenger health plans, challenger PBMs, and modern infrastructure platforms have emerged to meet the demand for better employer-sponsored healthcare. Their challenge and opportunity is to serve their two audiences at once – improving employer economics and risk while meeting the higher standard employees now have for their healthcare experience. Many of these emerging companies have the opportunity to be both AI-native and AI-proof.

And the plans that replace the traditional options might look pretty different. If we look at the various ways challenger health plans are trying to compete, a common theme is that plans are becoming more upstream, personalized, and proactive. They’re becoming more involved in how consumers actually navigate seeking and receiving care instead of just financing and administering it. AI helps enable the evolution from passive to active across these dimensions.

So this is a generational moment to rebuild the commercial health plan. But in an increasingly crowded market of startups, the question is not whether there’s a compelling “why now” – it’s which of these levers, or combination of them, can become a real, durable advantage.

How Challenger Health Plans Can Compete

A challenger health plan might get attention with a superior customer experience or lower admin fees, but the ultimate test is whether it can keep its members healthier and control the total cost of care. Across the health insurance plan ‘stack,’ there are a few places where an upstart can build a meaningful advantage:

And of course, a company can integrate several of these components into a full-stack health plan offering. Given the massive market opportunity, any one of these components could support a standalone company, or become a superpower within a full-stack health plan. And each segment of the employer market, from SMB to jumbo, is a big enough prospect base for a company to focus there for years and still grow significantly before expanding beyond.

Rising costs are forcing employers to shop, just as AI is making health plans smarter and cheaper to build, and consumers are expecting more from them. Health plans have to compete again, and a previously impenetrable market category is now addressable for startups.

Commercial health insurance is one of the largest markets in healthtech. It’s a control vector for how healthcare is priced, accessed, and experienced, and it’s one of the hardest layers to rebuild. For the first time in decades, employers are ready to buy something fundamentally different – and builders have better tools to deliver it.

If you are building a challenger health plan, we’d love to hear from you. Let us know the one or two levers where your approach is structurally different, and why that difference compounds as you scale.

Special thanks to Colin Morelli, Seth Cohen, and Eva Steinman for their contributions to this piece.

Want More a16z Bio + Health?

Insights, analysis, and additional reading on bio and health, and how both are shaping our future.

Learn More

Expert News by a16z

We have built a network of experts who are deeply rooted in technology and how it’s shaping our future. Subscribe to our newsletters to receive their perspectives.

Views expressed in “posts” (including podcasts, videos, and social media) are those of the individual a16z personnel quoted therein and are not the views of a16z Capital Management, L.L.C. (“a16z”) or its respective affiliates. a16z Capital Management is an investment adviser registered with the Securities and Exchange Commission. Registration as an investment adviser does not imply any special skill or training. The posts are not directed to any investors or potential investors, and do not constitute an offer to sell — or a solicitation of an offer to buy — any securities, and may not be used or relied upon in evaluating the merits of any investment.

The contents in here — and available on any associated distribution platforms and any public a16z online social media accounts, platforms, and sites (collectively, “content distribution outlets”) — should not be construed as or relied upon in any manner as investment, legal, tax, or other advice. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment. Any projections, estimates, forecasts, targets, prospects and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others. Any charts provided here or on a16z content distribution outlets are for informational purposes only, and should not be relied upon when making any investment decision. Certain information contained in here has been obtained from third-party sources, including from portfolio companies of funds managed by a16z. While taken from sources believed to be reliable, a16z has not independently verified such information and makes no representations about the enduring accuracy of the information or its appropriateness for a given situation. In addition, posts may include third-party advertisements; a16z has not reviewed such advertisements and does not endorse any advertising content contained therein. All content speaks only as of the date indicated.

Under no circumstances should any posts or other information provided on this website — or on associated content distribution outlets — be construed as an offer soliciting the purchase or sale of any security or interest in any pooled investment vehicle sponsored, discussed, or mentioned by a16z personnel. Nor should it be construed as an offer to provide investment advisory services; an offer to invest in an a16z-managed pooled investment vehicle will be made separately and only by means of the confidential offering documents of the specific pooled investment vehicles — which should be read in their entirety, and only to those who, among other requirements, meet certain qualifications under federal securities laws. Such investors, defined as accredited investors and qualified purchasers, are generally deemed capable of evaluating the merits and risks of prospective investments and financial matters.

There can be no assurances that a16z’s investment objectives will be achieved or investment strategies will be successful. Any investment in a vehicle managed by a16z involves a high degree of risk including the risk that the entire amount invested is lost. Any investments or portfolio companies mentioned, referred to, or described are not representative of all investments in vehicles managed by a16z and there can be no assurance that the investments will be profitable or that other investments made in the future will have similar characteristics or results. A list of investments made by funds managed by a16z is available here: https://a16z.com/investments/. Past results of a16z’s investments, pooled investment vehicles, or investment strategies are not necessarily indicative of future results. Excluded from this list are investments (and certain publicly traded cryptocurrencies/ digital assets) for which the issuer has not provided permission for a16z to disclose publicly. As for its investments in any cryptocurrency or token project, a16z is acting in its own financial interest, not necessarily in the interests of other token holders. a16z has no special role in any of these projects or power over their management. a16z does not undertake to continue to have any involvement in these projects other than as an investor and token holder, and other token holders should not expect that it will or rely on it to have any particular involvement.

With respect to funds managed by a16z that are registered in Japan, a16z will provide to any member of the Japanese public a copy of such documents as are required to be made publicly available pursuant to Article 63 of the Financial Instruments and Exchange Act of Japan. Please contact compliance@a16z.com to request such documents.

For other site terms of use, please go here. Additional important information about a16z, including our Form ADV Part 2A Brochure, is available at the SEC’s website: http://www.adviserinfo.sec.gov.